USPTO serial 79360498
LIGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 14, 2024
- Examiner
- WATTS-FITZGERALD, CAITLIN C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LIGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teaching, specifically, for granting user access to courses of instruction in the medical field; downloadable virtual screening software, specifically, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, and facilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration software platforms for use in database management in the field of medicine; downloadable computer software platforms for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable artificial intelligence software for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models in the field of healthcare | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing temporary use of online, non-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; design and development of virtual screening software; design and development of virtual reality software for teaching medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dompe' farmaceutici Spa
- Other trademarks owned by Dompe' farmaceutici Spa
- Other trademarks owned by Dompe' farmaceutici Spa
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named LIGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 26, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 26, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 26, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 26, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 26, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 7, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 7, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 14, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 14, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 14, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 27, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 26, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 7, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 7, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 7, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 23, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 11, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 11, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 11, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 11, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 11, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 17, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 25, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 25, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 7, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 24, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 19, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |